SCHEMBL5484164

SCHEMBL5484164

CC(C)c1oc(-c2cccc(C(F)(F)F)c2)nc1COCC1CCCC(COC(C)(C)C(=O)O)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 10/20 0.40
PPARA Q07869 10/20 0.40
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
SLC16A3 O15427 3/20 0.37
SLC16A1 P53985 3/20 0.37
MCTS1 Q9ULC4 2/20 0.37
PPARD Q03181 4/20 0.37
MAPT P10636 2/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
KDM4E B2RXH2 1/20 0.34
CNR2 P34972 1/20 0.34
CETP P11597 1/20 0.34
KCNH2 Q12809 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4373520 1.00 PPARG (0.40) PPARGPPARAALDH1A1MEN1KMT2A
SCHEMBL4482451 1.00 PPARG (0.40) PPARGPPARAALDH1A1MEN1KMT2A
SCHEMBL4382433 1.00 PPARG (0.40) PPARGPPARAALDH1A1MEN1KMT2A
SCHEMBL4478661 1.00 PPARG (0.40) PPARGPPARAALDH1A1MEN1KMT2A
SCHEMBL4384388 0.96 PPARG (0.38) PPARGPPARAALDH1A1MEN1KMT2A
SCHEMBL4478526 0.91 PPARA (0.41) PPARGPPARAALDH1A1MEN1KMT2A
SCHEMBL4373453 0.91 PPARA (0.41) PPARGPPARAALDH1A1MEN1KMT2A
SCHEMBL4480680 0.90 PPARG (0.42) PPARGPPARAPPARDCETP
SCHEMBL4380140 0.90 PPARG (0.42) PPARGPPARAPPARDCETP
SCHEMBL4479975 0.88 SLC16A3 (0.43) PPARGPPARAALDH1A1KMT2ASLC16A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070197612-A1 2-{-3-'2-(PHENYL)-OXAZOL-4-YLMETHOXYMETHYL-CYCLOHEXYLMETHOXY}-PROPIONIC ACID DERIVATIVES USEFUL AS PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) LIGANDS FOR THE TREATMENT OF HYPERLIPIDEMIA AND DIABETES SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197612-A1 2-{-3-'2-(PHENYL)-OXAZOL-4-YLMETHOXYMETHYL-CYCLOHEXYLMETHOXY}-PROPIONIC ACID DERIVATIVES USEFUL AS PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) LIGANDS FOR THE TREATMENT OF HYPERLIPIDEMIA AND DIABETES PPARA, PPARG, PPARD PPARG 2/4885PPARA 1/4885ALDH1A1 448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.